2024
Cutaneous sarcoidosis: clinical and pathologic features, molecular pathogenesis, and treatment
Damsky W, King B. Cutaneous sarcoidosis: clinical and pathologic features, molecular pathogenesis, and treatment. Clinics In Dermatology 2024 PMID: 39694198, DOI: 10.1016/j.clindermatol.2024.12.017.Peer-Reviewed Original ResearchCutaneous manifestations of sarcoidosisManifestation of sarcoidosisMultisystem inflammatory disorderFDA-approved therapiesLevel of evidenceCutaneous involvementCutaneous sarcoidosisCutaneous manifestationsHistopathological findingsInflammatory disordersSarcoidosisLymphatic systemTreatment approachesDisease pathogenesisRecommended evaluationDiseasePrednisoneCorticotropinTherapyPatientsMultisystemLungPathogenesis
2023
Molecularly Targeted Therapies for Inflammatory Cutaneous Granulomatous Disorders: A Review of the Evidence and Implications for Understanding Disease Pathogenesis
Hwang E, Abdelghaffar M, Shields B, Damsky W. Molecularly Targeted Therapies for Inflammatory Cutaneous Granulomatous Disorders: A Review of the Evidence and Implications for Understanding Disease Pathogenesis. JID Innovations 2023, 3: 100220. PMID: 37719661, PMCID: PMC10500476, DOI: 10.1016/j.xjidi.2023.100220.Peer-Reviewed Original ResearchDisease pathogenesisCutaneous granulomatous disordersLow-quality evidenceRepository corticotropin injectionOutcome of treatmentImmunomodulatory medicationsPulmonary sarcoidosisCutaneous sarcoidosisGranulomatous disorderNecrobiosis lipoidicaCorticotropin injectionMacrophage accumulationGranuloma annulareGranulomatous diseaseCutaneous granulomatous diseasesTargeted therapyDrug AdministrationMolecular pathogenesisNew treatmentsSystematic reviewPathogenesisTherapyDistinct diseasesTherapeutic innovationsDisease